---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-004128"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2023-02-23T23:59:59+00:00"
generated_at: "2026-06-19T03:23:32.103864+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Definitive Healthcare Q4 revenue up 31% to $60.6M; FY23 guidance implies 14% growth

## Summary
- Q4 revenue $60.6M (+31% YoY); GAAP net income $6.7M vs loss $14.8M in Q4 2021.
- Full year 2022 revenue $222.7M (+34%); GAAP net loss $22.3M vs $61.3M loss prior year.
- Adjusted EBITDA Q4 $17.0M (28% margin); full year $63.7M (29% margin).
- Q1 2023 revenue guidance $56.5-58.5M (median +15% YoY); FY2023 revenue $249-255M (+14% at midpoint).
- Executive Chairman Jason Krantz base salary reduced to $1,000/week, granted 18,465 RSUs, no 2023 bonus; CEO/CFO/Chairman received cash bonuses for 2022 despite missing targets.

## SEC filing metadata
- accession: 0000950170-23-004128
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2023-02-23T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/0000950170-23-004128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/dh-20230216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-004128
- JSON: https://secwatch.observer/filing/0000950170-23-004128.json
- Plain text: https://secwatch.observer/filing/0000950170-23-004128.txt

## Key facts
- Earnings Releases
  Definitive Healthcare Corp. reported fourth quarter ended December 31, 2022 results: revenue $60.6 million, net income $6.7 million. Guidance initiated.
  - Period: fourth quarter ended December 31, 2022
  - Revenue: $60.6 million
  - Net income: $6.7 million
  - Guidance: initiated
  - Result: reported results
  source text: Fourth Quarter 2022 Financial Highlights: • Revenue was $60.6 million, an increase of 31% from $46.3 million in Q4 2021. • GAAP Net Income (loss) was $6.7 million, or 11% of revenue, compared to $(14.8) million, or 32% of revenue in Q4 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/0000950170-23-004128-index.htm
- Earnings Releases
  Definitive Healthcare Corp. reported full year ended December 31, 2022 results: revenue $222.7 million, net income $(22.3) million. Guidance initiated.
  - Period: full year ended December 31, 2022
  - Revenue: $222.7 million
  - Net income: $(22.3) million
  - Guidance: initiated
  - Result: reported results
  source text: Full Year 2022 Financial Highlights: • Revenue was $222.7 million for the year, an increase of 34% from $166.2 million for the full year 2021. • GAAP Net loss was $(22.3) million, or 10% of revenue, compared to $(61.3) million, or 37% of revenue for the full year 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/0000950170-23-004128-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.